إسرائيل - العربية - Ministry of Health

dexcel ltd - omeprazole 20 mg - caplets - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

إسرائيل - العربية - Ministry of Health

dexcel ltd - metformin hydrochloride 850 mg - caplets - metformin - treatment of non-insulin diabetes mellitus not responding to dietary modification.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - repaglinide 1 mg - tablets - repaglinide - treatment of type ii diabetes.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - atenolol 100 mg - tablets - atenolol - management of angina pectoris and hypertension,including hypertension of renal origin. late intervention after acute myocardial infarction.

إسرائيل - العربية - Ministry of Health

abic ltd. - atenolol 50 mg - tablets - atenolol - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - ramipril 5 mg - tablets - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

إسرائيل - العربية - Ministry of Health

sanofi - aventis israel ltd - hydrochlorothiazide 12.5 mg; ramipril 2.5 mg - tablets - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.